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Abstract 
We present two cases of orbital meningioma
which were totally excised by a neurosurgical
and craniomaxillofacial team using skull base
approaches. 
Introduction
We present two cases of orbital meningioma
which were totally excised by a neurosurgical
and craniomaxillofacial team using skull base
approaches. 
Orbital meningioma is relatively rare; they
accounted for only 4% of orbital masses in a
series  of  1246.
1 Although  locally  invasive,
meningioma  has  a  favorable  prognosis  is  if
completely removed.
2
Case Reports
Case #1
A 6-year-old girl consulted the department of
neurosurgery  complaining  of  acute  loss  of
vision in the left eye of 6 months’ duration.
Visual activity was 1.2/1.2 OD and no light per-
ception  OS.  Magnetic  resonance  imaging
(MRI) indicated a mass around the optic nerve
within the left orbital apex (Figure 1). 
Tumor excision was performed via frontal
craniotomy and orbitotomy. Because the mass
measuring  2.3¥0.5  cm  was  adherent  to  the
optic nerve, it was excised completely along
with the optic nerve (Figure 2). Histological
examinations showed that the tumor consisted
of  bundles  of  spindle-shaped  cells  within  a
psammomatous  body.  Immunohistochemical
staining  revealed  that  the  tumor  cells  were
positive for keratin and involucrin, were nega-
tive for S-100 protein and epithelial membrane
antigen. MRI of the orbit after surgery revealed
no residual tumor.   There was no evidence of
recurrence 3 years after surgery.
Case #2
A 59-year-old man presented with acute loss
of  light  perception  in  the  right  eye  of  6
months’ duration. He had been examined at
the department of ophthalmology 3 years pre-
viously. At that time visual activity was 1.2/1.5
OD and 1.2/1.2 OS, and ophthalmologic exam-
ination showed 3-mm proptosis of the right
eye. MRI indicated a mass within the right
orbital apex which was diagnosed as a menin-
gioma. The patient was evaluated by a neuro-
surgeon, who recommended regular follow-up
and treatment with cortico steroids. However,
3  years  later  the  patient’s  eyesight  rapidly
deteriorated  such  that  visual  activity  was
counting  fingers  OD  and  1.2/1.2  OS.
Ophthalmologic  examination  showed  4-mm
proptosis of the right eye. An MRI revealed a
well-defined  mass  measuring  2.0¥2.0  cm  in
the retrobulbar compartment of the right orbit
(Figure  3).  Computed  tomography  indicated
no involvement of bony structures.  
Frontal  craniotomy  with  orbitotomy  and
complete removal of the tumor was performed.
Although the tumor enclosed the optic nerve, it
had  not  invaded  to  either  the  nerve  or  the
orbital  wall  and  could  be  separated  easily.
Histological  examinations  showed  that  solid
nests  of  meningothelial  cells  arranged  in
whorls. Immunohistochemical studies showed
that, most tumor cells were positive for S-100
protein  and  focally  positive  for  Ki-67.  These
findings  indicated  that  the  tumor  was  a
meningothelial  meningioma.  Ocular  move-
ment  recovered  completely  and  proptosis
resolved within 1 year of surgery. There was no
evidence of recurrence 4 years after surgery.
Discussion
Extracranial  meningiomas  are  unusual
tumors that sometimes occur in the skin or
soft tissue of the scalp or along the vertebral
axis.
3 In particular, orbital meningiomas are so
rare that only 53 (4%)were found in 1264 con-
secutive patients referred for an orbital mass,
and Dalia and Neil reported that optic nerve
sheath  meningiomas  comprise  1-2%  of  all
meningiomas.
1,4
Although  extracranial  meningiomas  arise
from ectopic arachnoid linking cells, their pre-
cise  presentation  suggests  two  pathogenetic
mechanisms. One form, termed type I, usually
gives rise to cutaneous lesions and is believed
to be the result of abnormalities of neural tube
closure.  The  second  form  (type  II)  arises
around sensory organs or along the cranial and
spinal  nerves.
5 Orbital  meningiomas  arise
from the skull base and spread via the sphe
noid ridge and the optic canal.
2 Case #1 origi-
nating  in  the  arachnoid  layer  of  the  optic
nerve, was categorized as type II and was des-
ignated  a  typical  optic  sheath  meningioma.
Although its form was not irregular, the tumor
of case 2 was also considered to have originat-
ed from the optic nerve because it was sepa-
rate from the intracranial meninges.
Most  orbital  meningiomas  present  with  a
slowly  progressive  optic  neuropathy  charac-
terised  by  a  variable  loss  of  visual  acuity.
However, our cases showed acute loss of vision
of 6 months’ duration. Approximately 4-7% of
optic  nerve  sheath  meningiomas  occur  in
childhood,  and  they  grow  faster,  involve
intracranial space more frequently than occurs
in adults.
6
Traditionally,  orbital  meningiomas  have
been observed without intervention, or treated
by excision of the tumor along with the nerve
because  of  difficulty  of  surgical  approach.
Attempts to excise these tumors while keeping
the optic nerve intact had been unsuccessful.
7
Berman et al. reviewed 150 articles and eval-
uated their over 100 cases of orbital menin-
gioma, and reported that the short-term effica-
cy  of  stereotactic  fractionated  radiotherapy
(SFR)in  preserving  or  improving  vision
appears to be excellent, with more than half of
the patients having an improvement within 3
months  following  treatment.  They  concluded
that SFR is the best option for most cases of
progressive  or  advanced  disease.
4 However,
late toxicity due to irradiation are sometimes
seen  including  the  optic  nerve,  retina,  pitu-
itary gland, and the white-matter tracts of the
brain.
8 Retinal injury has been described with
exposures of more than 50 Gy.
9 Late non-ocular
side effects were also reported such as pitu-
itary dysfunction and cerebral punctate small-
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vessel  fallout.
4 These  undesirable  complica-
tions bring continuous distress for the patients
and decrease their quality of life.  
Extensive  removal  of  orbital  meningioma
which is located in the posterior orbit is rec-
ommended  because  it  prevents  recurrence.
10
Orbital  apex  tumors  were  considered  to  be
unresectable previously, because of the risks
involved  with  surgical  intervention.
11
However, skull base approaches by a neurosur-
gical  and  craniomaxillofacial  team  provide
excellent exposure of important neurovascular
structures and enable total and extensive abla-
tion of a retrobulbar mass.
10 We conclude that
basal frontal craniotomy contributes to a suc-
cessful,  complete  excision  of  retrobulbar
meningiomas.  Thus,  extensive  removal  of
orbital  meningioma  through  an  extradural
route is recommended as a favorable option for
patients with progressive or advanced retrob-
ulbar meningioma.
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Case Report
Figure 1. Axial magnetic resonance imag-
ing  of  case  1  revealed  a  mass  measuring
2.3¥0.5  cm  (arrow).  It  enclosed  and
adhered to the optic nerve. 
Figure 2. Intraoperative view of case #1.
The  tumor  around  the  optic  nerve  was
exposed though a defect of the orbital roof
after orbitotomy. 
Figure 3. Axial magnetic resonance imag-
ing  of  case  2  revealed  a  mass  measuring
2.0¥2.0  cm  in  the  retrobulbar  compart-
ment of the right orbit causing proptosis.  